Sectoral Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Sectoral Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$787K	Sell	31,680 -29,520	-48%	-$641K	0.65%	39
2025 Q4	$1.29M	Sell	61,200 -18,230	-23%	-$318K	1.03%	29
2025 Q3	$1.22M	Buy	79,430 +16,130	+25%	+$211K	0.75%	46
2025 Q2	$593K	Buy	+63,300	New	+$697K	0.39%	65
2024 Q1	–	Sell	-92,060	Closed	-$1.99M	–	107
2023 Q4	$1.99M	Buy	+92,060	New	+$1.42M	0.86%	43

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Sectoral Asset Management's SNDX Position: Q1 2026 in Review

Sectoral Asset Management reduced its Syndax Pharmaceuticals (SNDX) stake by 48% in Q1 2026, selling an estimated $641K and leaving 31,680 shares worth $787K. The position accounts for 0.65% of the portfolio, ranked #39.

Sectoral Asset Management first reported a position in SNDX in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.99M in Q4 2023. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

Sectoral Asset Management held 31,680 shares of Syndax Pharmaceuticals worth $787K as of Q1 2026.
Sectoral Asset Management sold 29,520 Syndax Pharmaceuticals shares in Q1 2026, an estimated $641K.
Syndax Pharmaceuticals made up 0.65% of Sectoral Asset Management's portfolio in Q1 2026, its #39 holding.
Sectoral Asset Management first reported a position in Syndax Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
Sectoral Asset Management's Syndax Pharmaceuticals position peaked at $1.99M in Q4 2023.
246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.